AH

Aaron Hata

Scientific Advisor at Nuvalent

Aaron is an Assistant Professor of Medical at Harvard Medical School and an Assistant Physician of Medicine at Massachusetts General Hospital. He is an accomplished scientist whose work focuses on advancing targeted therapies to benefit patients with lung cancer. His lab focuses on understanding the biological underpinnings of sensitivity and resistance to kinase inhibitor targeted therapies in lung cancers with specific genetic abnormalities (EGFR mutations, ALK translocations, KRAS mutations). Specifically, he is interested in discovering targetable mechanisms that promote tumor evolution and acquired drug resistance. Aaron earned his MD and PhD from Vanderbilt University School of Medicine, conducted his internship and residency in Internal Medicine at Brigham and Women’s Hospital, and completed Medical Oncology fellowship training at Dana Farber Cancer Institute and Massachusetts General Hospital.

Timeline

  • Scientific Advisor

    Current role